Journal

Introduction — When sleep becomes unstable for no apparent reason

Sleep disorders are among the most frequent reasons for consultation in women during perimenopause and menopause. Difficulty falling asleep, repeated night-time awakenings, night sweats, sleep fragmentation, and the feeling of non-restorative sleep despite sufficient time in bed affect a majority of women during this hormonal transition [1–4].

These disturbances often appear before the cessation of menstrual cycles, sometimes several years in advance. They tend to fluctuate initially, then become chronic when the underlying biological mechanisms are neither identified nor addressed [2,5]. This timeline is crucial: sleep is often one of the first systems to express a loss of overall physiological coherence.

This interpretation fully aligns with the Cellular Nutrition® approach, which considers sleep not as an isolated function, but as an integrated cellular process, dependent on the ability of cells to properly receive, interpret, and respond to metabolic, hormonal, and neuro-inflammatory signals.

Contrary to a still widespread assumption, these sleep disturbances are not simply the result of an isolated “hormonal deficiency.” Menopause acts as a systemic stressor, revealing and amplifying pre-existing vulnerabilities at the level of:

• circadian rhythms,
• the autonomic nervous system,
• nocturnal glucose metabolism,
• low-grade inflammation,
• mitochondrial function,
• hypothalamic thermoregulation,
• the gut microbiota and neurotransmitter production.

Sleep thus becomes a sensitive clinical marker of overall biological adaptability.

1. Why does menopause profoundly disrupt sleep?

1.1. Oestrogen decline and disruption of sleep architecture

Oestrogens play a key role at several essential levels of sleep regulation. In particular, they modulate:

• cerebral receptor sensitivity to melatonin,
• expression of circadian clock genes (CLOCK, BMAL1),
• stability of deep slow-wave sleep phases,
• nocturnal synaptic plasticity,
• central thermoregulation [6–9].

When oestrogen secretion becomes erratic and then persistently low, sleep architecture weakens. Sleep cycles become shorter, more superficial, and more sensitive to internal micro-stimuli. The proportion of deep slow-wave sleep decreases, compromising nocturnal metabolic, neuronal, and immune recovery [7,10].

The issue is therefore not simply “sleeping less,” but sleeping differently, with a loss of biological efficiency.

From a Cellular Nutrition® perspective, this loss of efficiency primarily reflects an alteration in the quality of the nocturnal signal perceived by the cell: energy signals, hormonal signals, redox signals, and circadian signals are no longer properly synchronised.

1.2. Autonomic nervous system imbalance

Perimenopause is frequently accompanied by hyperactivation of the sympathetic nervous system, combined with a reduction in parasympathetic tone. Clinically, this manifests as:

• night-time awakenings in a state of alertness,
• palpitations,
• difficulty falling back asleep,
• a sense of light, unstable, non-restorative sleep.

Physiologically, this hyperactivation is driven by the convergence of several factors: chronic stress, accumulated sleep debt, nocturnal glycaemic fluctuations, low-grade inflammation, and reduced levels of inhibitory neurotransmitters, particularly GABA [11–14].

Sleep therefore ceases to be a passive recovery state and becomes a biologically unstable phase, repeatedly interrupted by internal vigilance signals.

1.3. Hot flushes, thermoregulation, and sleep fragmentation

Hot flushes and night sweats are among the most disruptive factors affecting menopausal sleep. They result from a narrowing of the thermoneutral zone at the hypothalamic level, which becomes hypersensitive to minimal changes in core body temperature following oestrogen decline [15–17].

A very slight rise in central temperature can trigger an abrupt vasodilatory response accompanied by cortical arousal. These episodes preferentially interrupt deep sleep and REM sleep, preventing their continuous and restorative progression.

2. Menopausal insomnia: a documented multifactorial condition

Evidence from clinical and translational research converges on a clear conclusion: menopausal insomnia is multifactorial [3,18–20].

It combines, to varying degrees depending on the individual:

• dysregulation of cortisol, often inappropriately elevated in the evening,
• nocturnal glycaemic instability,
• chronic low-grade inflammation,
• alterations of the gut microbiota,
• reduced synthesis of serotonin and GABA,
• increased mitochondrial vulnerability.

This mitochondrial vulnerability is a central concept in Cellular Nutrition®: a cell with unstable or inefficient energy production becomes more sensitive to nocturnal micro-stressors, promoting micro-awakenings and sleep fragmentation.

This complexity explains why purely symptomatic approaches (hypnotics, sedatives) offer limited and transient benefits. While they may induce sedation, they do not improve deep sleep quality, nocturnal metabolic recovery, or circadian synchronisation [21].

3. Biologically preparing sleep: key levers

Within a Cellular Nutrition® framework, the focus shifts: the goal is no longer simply to induce sleep, but to restore the cellular conditions that allow sleep to unfold naturally, without pharmacological forcing or artificial compensation.

3.1. Stabilising nocturnal glycaemia

Awakenings between 2 a.m. and 4 a.m. are frequently associated with nocturnal hypoglycaemia, triggering compensatory secretion of cortisol and adrenaline [22–24].

A dinner that includes:

• sufficient protein intake,
• complex carbohydrates,
• stable, structurally supportive lipids,

helps limit these nocturnal fluctuations and reduces inappropriate neuroendocrine activation.

3.2. Circadian rhythm and central synchronisation

Restoring sleep requires resynchronisation of the central biological clock: exposure to natural daylight in the morning, reduction of artificial light in the evening, and consistent bedtimes and wake-up times. These levers directly influence melatonin secretion and the coherence of sleep–wake cycles [25–27].

3.3. Inflammation, gut health, and neurotransmitters

The link between intestinal dysbiosis, low-grade inflammation, and sleep disturbances is now firmly established [28–31].

An imbalanced microbiota can reduce serotonin production, impair its nocturnal conversion into melatonin, increase intestinal permeability, and sustain systemic inflammatory activation, thereby amplifying sleep instability.

This gut–brain interaction is one of the pillars of Cellular Nutrition®, in which the microbiota is considered a signalling organ, capable of directly influencing sleep–wake rhythms through neurotransmitters, inflammation, and cellular metabolism.

4. Supplementation: a mechanistic reading of Méthode Espinasse formulas

Within a Cellular Nutrition® logic, supplementation does not aim to compensate for an isolated deficiency, but to support key cellular pathways involved in stress adaptation, energy production, neuro-hormonal signalling, and circadian coherence.

No.0 OPTIMAL — chronic fatigue, fragmented sleep, and mitochondrial vulnerability

The No.0 OPTIMAL formula combines magnesium bisglycinate, rhodiola, tyrosine, coenzyme Q10, zinc, B-group vitamins, vitamin D3, and probiotics (Bifidobacterium longum, Lactobacillus acidophilus).

Biologically, this combination targets several mechanisms involved in menopausal sleep disturbances:

• support of mitochondrial function (CoQ10, B vitamins),
• improved stress resilience (rhodiola, magnesium),
• support of neurotransmitter synthesis (tyrosine, B vitamins),
• modulation of the gut–brain axis (probiotics),
• reduction of low-grade inflammation (zinc, vitamin D).

No.0 OPTIMAL therefore acts as a metabolic and neurobiological foundation, particularly relevant when sleep disturbances occur in a context of chronic fatigue and reduced vitality. It fits squarely within Cellular Nutrition®, acting on the cellular determinants of nocturnal adaptation rather than on sleep symptoms alone.

No.5 OIL — lipids, inflammation, and neuroendocrine stability

No.5 OIL is based on evening primrose oil, rich in gamma-linolenic acid (GLA).

GLA is involved in:

• the synthesis of anti-inflammatory prostaglandins,
• modulation of low-grade inflammation,
• neuronal membrane fluidity,
• hormonal signalling.

In menopausal women, this lipid action indirectly contributes to sleep stability, particularly when night-time awakenings are associated with chronic inflammation or pronounced hormonal fluctuations [32–34].

No.9 HARMONY — neuro-hormonal regulation and the oestrobolome

No.9 HARMONY combines hormone-regulating plants (Vitex agnus-castus, Angelica sinensis, Alchemilla vulgaris) with probiotics targeting the oestrobolome.

This approach aims to:

• modulate the hypothalamic–pituitary axis,
• restore prolactin/progesterone balance,
• influence intestinal oestrogen recirculation,
• reduce the neurovegetative impact of hormonal fluctuations.

By stabilising the hormonal and inflammatory environment, No.9 HARMONY indirectly improves sleep quality by reducing disruptive nocturnal biological signals [35–38].

No.7 MOON — supporting the physiological mechanisms of sleep

The No.7 MOON formula combines mild sedative plants (passionflower, hawthorn, California poppy, valerian, lemon balm), B-group vitamins, Lactobacillus helveticus, and melatonin.

It acts on several levels:

• reduction of neurovegetative hyperactivity,
• support of neurotransmitter synthesis,
• modulation of the gut–brain axis,
• provision of a physiological temporal sleep signal.

No.7 MOON does not force sleep. It supports sleep onset and continuity, respecting natural sleep architecture, in a manner fully aligned with Cellular Nutrition®.

Conclusion — Sleep as an indicator of biological coherence

Sleep disturbances during menopause are neither trivial nor inevitable. They most often represent a warning signal, revealing broader disorganisation: hormonal, metabolic, inflammatory, digestive, and neurovegetative.

The Cellular Nutrition® approach enables this shift in perspective: viewing sleep as an expression of overall cellular coherence, rather than as an isolated function to be corrected.

Restoring restorative sleep during menopause is not a matter of willpower, but of biological realignment.

FAQ

1) Why does sleep often worsen as early as perimenopause?

Because early oestrogen fluctuations can disrupt circadian regulation, thermoregulation, and autonomic balance well before periods stop. Sleep is often one of the first systems to reflect this biological instability [1–3,6].

2) Are menopausal sleep problems “just hormonal”?

No. Current evidence supports a multifactorial picture: hormones, cortisol, nocturnal glycaemia, low-grade inflammation, the gut microbiota, neurotransmitters, and mitochondrial function interact simultaneously [3,18–20].

3) Why do I keep waking up between 2 a.m. and 4 a.m.?

These awakenings are frequently linked to nocturnal glycaemic instability and counter-regulatory stress responses (cortisol/adrenaline), which can trigger cortical arousal [22–24].

4) What is the link between menopause, stress, and the nervous system at night?

Oestrogen decline can promote sympathetic hyperactivation and reduced parasympathetic tone, making sleep lighter, more fragmented, and more reactive to internal micro-stressors [11–14].

5) Do hot flushes and night sweats directly cause night-time awakenings?

Often, yes. They reflect hypothalamic thermoregulation hypersensitivity: even small changes in core temperature can trigger arousal and disrupt deep sleep [15–17].

6) Why can sleep feel non-restorative even if I sleep “enough” hours?

Because sleep architecture changes: deep slow-wave sleep may decrease and cycles become more fragmented, reducing biological recovery even when time in bed is adequate [7,10].

7) What role does the gut microbiota play in sleep?

The microbiota influences serotonin production, melatonin pathways, inflammation, gut permeability, and the gut–brain axis—factors that can affect sleep–wake regulation [28–31].

8) How does low-grade inflammation disturb sleep?

Chronic inflammation acts as a persistent biological stress signal, increasing nocturnal autonomic activation and reducing sleep continuity and stability [20,28,31].

9) How does Cellular Nutrition® change the way we approach sleep in menopause?

Cellular Nutrition® frames sleep as an integrated cellular process, dependent on the quality and synchronisation of energy, hormonal, redox, inflammatory, and circadian signals—rather than a symptom to suppress.

10) Why are sleeping pills often not a long-term solution?

They may induce sedation but do not reliably improve deep sleep quality, nocturnal metabolic restoration, or circadian alignment, and can carry dependence risks [21].

11) Does dinner composition really affect menopausal sleep?

Yes. Meals that are too low in protein or high in rapidly absorbed sugars can increase nocturnal glycaemic swings and early-morning awakenings. The evening meal is a key lever [22–24].

12) Why does mitochondrial function matter for sleep?

Night-time recovery is energy-dependent. When mitochondrial resilience is reduced, the system becomes more sensitive to nocturnal micro-stressors, promoting micro-awakenings and fragmentation [19,20].

13) What is the rationale for No.0 OPTIMAL in menopausal sleep issues?

No.0 OPTIMAL supports cellular determinants relevant to sleep: mitochondrial energy pathways, stress resilience, neurotransmitter synthesis, gut–brain signalling, and low-grade inflammation modulation—consistent with a Cellular Nutrition® approach [19–21].

14) How can the lipids in No.5 OIL influence sleep?

Gamma-linolenic acid (from evening primrose oil) can modulate inflammatory pathways, hormonal signalling, and neuronal membrane fluidity—factors that may indirectly support night-time stability in some profiles [32–34].

15) How can No.9 HARMONY support sleep during menopause?

By modulating the hypothalamic–pituitary axis and targeting the oestrobolome, it aims to reduce the neurovegetative impact of hormonal fluctuations that can disrupt sleep [35–38].

16) Is No.7 MOON basically a sedative?

No. It is not designed to “force” sleep. It supports physiological sleep onset and continuity while respecting sleep architecture, rather than acting as a heavy sedative [27,38].

17) Can menopausal sleep be improved sustainably?

Yes—when interventions address underlying mechanisms: circadian cues, inflammation, metabolism, the microbiota, autonomic balance, and cellular resilience [3,18–20].

18) Is sleep a marker of overall health during menopause?

Yes. In a Cellular Nutrition® framework, sleep can be viewed as a sensitive marker of global cellular coherence, reflecting hormonal, metabolic, inflammatory, digestive, and neurovegetative adaptation [1–5].

Bibliography

[1] Freeman EW et al. Sleep disturbance in menopause. Menopause (2015).
https://pubmed.ncbi.nlm.nih.gov/26035152/

[2] Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America (2015).
https://pubmed.ncbi.nlm.nih.gov/26316239/

[3] National Institute on Aging (NIH). Menopause and sleep problems.
https://www.nia.nih.gov/health/menopause-and-sleep

[4] INSERM. Ménopause : symptômes et conséquences systémiques. (French institutional dossier)
https://www.inserm.fr/dossier/menopause/

[5] Harvard Health Publishing. Why menopause disrupts sleep.
https://www.health.harvard.edu/womens-health/why-menopause-disrupts-sleep

[6] Polo-Kantola P. Sleep problems in midlife women. Sleep Medicine Reviews (2011).
https://pubmed.ncbi.nlm.nih.gov/21377456/

[7] Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Medicine (2007).
https://pubmed.ncbi.nlm.nih.gov/17368003/

[8] Mong JA et al. Hormonal regulation of sleep and circadian rhythms. Journal of Neuroscience (2011).
https://www.jneurosci.org/content/31/45/16103

[9] Cusmano DM, Hadjimarkou MM. Estrogen and sleep. Current Sleep Medicine Reports (2019).
https://pubmed.ncbi.nlm.nih.gov/31392626/

[10] Kravitz HM et al. Sleep difficulty in women at midlife. Archives of Internal Medicine (2008).
https://pubmed.ncbi.nlm.nih.gov/18981386/

[11] McEwen BS. Stress, adaptation, and disease: Allostasis and allostatic load. Annals of the New York Academy of Sciences (1998).
https://pubmed.ncbi.nlm.nih.gov/9500470/

[12] Thayer JF, Lane RD. Claude Bernard and the heart–brain connection: Further elaboration of a model of neurovisceral integration. Neuroscience & Biobehavioral Reviews (2009).
https://pubmed.ncbi.nlm.nih.gov/19497331/

[13] Goldstein DS. Adrenal responses to stress. Endocrine Reviews (2010).
https://pubmed.ncbi.nlm.nih.gov/19934347/

[14] Autonomic imbalance and sleep (Frontiers article). Frontiers in Neuroscience (2021).
https://www.frontiersin.org/articles/10.3389/fnins.2021.643568

[15] Freedman RR. Physiology of hot flashes. American Journal of Human Biology (2001).
https://pubmed.ncbi.nlm.nih.gov/11494149/

[16] Kronenberg F. Hot flashes: epidemiology and physiology. Annals of the New York Academy of Sciences (1990).
https://pubmed.ncbi.nlm.nih.gov/2245035/

[17] Vasomotor symptoms in menopause (Lancet Diabetes & Endocrinology article page).
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30102-2

[18] Joffe H et al. Depression and insomnia in menopause. Journal of Clinical Endocrinology & Metabolism (2010).
https://pubmed.ncbi.nlm.nih.gov/20089621/

[19] Xu Q et al. Menopause and metabolic dysregulation. Cell Metabolism (2020).
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30244-1

[20] Irwin MR. Sleep and inflammation: partners in sickness and in health. Brain, Behavior, and Immunity (2019).
https://pubmed.ncbi.nlm.nih.gov/30513344/

[21] Hypnotics and sleep quality (BMJ feature/review page). BMJ (2015).
https://www.bmj.com/content/350/bmj.h1998

[22] Service FJ. Hypoglycemia and counterregulation. New England Journal of Medicine (1995).
https://www.nejm.org/doi/full/10.1056/NEJM199506223322507

[23] Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure. The American Journal of Medicine (2007).
https://pubmed.ncbi.nlm.nih.gov/17398243/

[24] Nocturnal glycaemia and sleep fragmentation (Nutrients review/article). Nutrients (2020).
https://www.mdpi.com/2072-6643/12/9/2625

[25] Czeisler CA et al. Circadian regulation of sleep. Science (1999).
https://www.science.org/doi/10.1126/science.284.5423.2177

[26] Gooley JJ et al. Exposure to room light before bedtime suppresses melatonin onset. JCEM (2011).
https://pubmed.ncbi.nlm.nih.gov/21490185/

[27] Walker MP. Sleep and brain function (review page). Nature Reviews Neuroscience (2017).
https://www.nature.com/articles/nrn.2017.23

[28] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience (2012).
https://pubmed.ncbi.nlm.nih.gov/22642663/

[29] Strandwitz P. Neurotransmitters and the microbiota (Cell article page). Cell (2018).
https://www.cell.com/cell/fulltext/S0092-8674(18)30041-6

[30] Valles-Colomer M et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology (2019).
https://www.nature.com/articles/s41564-018-0337-x

[31] Microbiota, inflammation and sleep (Gut journal page). Gut (2021).
https://gut.bmj.com/content/70/5/837

[32] Horrobin DF. Gamma-linolenic acid and prostaglandins. Progress in Lipid Research (1992).
https://pubmed.ncbi.nlm.nih.gov/1362114/

[33] Fan YY, Chapkin RS. Omega-6 fatty acids and inflammation. The Journal of Nutrition (1998).
https://pubmed.ncbi.nlm.nih.gov/9722749/

[34] Evening primrose oil and menopausal symptoms (Menopause journal record). Menopause (2013).
https://pubmed.ncbi.nlm.nih.gov/23571540/

[35] Wuttke W et al. Vitex agnus-castus: pharmacology and clinical implications. Phytomedicine (2003).
https://pubmed.ncbi.nlm.nih.gov/14515703/

[36] European Medicines Agency (EMA). Assessment report: Vitex agnus-castus L., fructus.
https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-vitex-agnus-castus-l-fructus_en.pdf

[37] Pluijm SMF et al. Oestrobolome and oestrogen metabolism (Frontiers review/article). Frontiers in Endocrinology (2020).
https://www.frontiersin.org/articles/10.3389/fendo.2020.00025

[38] Melatonin, microbiota and sleep (Sleep Medicine Reviews record). Sleep Medicine Reviews (2021).
https://pubmed.ncbi.nlm.nih.gov/33434779/